BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 9452264)

  • 1. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
    Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
    Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
    J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.
    Sjögren H; Orndal C; Tingby O; Meis-Kindblom JM; Kindblom LG; Stenman G
    Int J Oncol; 2004 Jun; 24(6):1385-91. PubMed ID: 15138578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic findings in 14 benign cartilaginous neoplasms.
    Sakai Junior N; Abe KT; Formigli LM; Pereira MF; de Oliveira MD; Cornelio DA; de La Roque Ferreira A; Kalil RK
    Cancer Genet; 2011 Apr; 204(4):180-6. PubMed ID: 21536235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pericentromeric inversion, inv (6)(p25q13), is a novel diagnostic marker in chondromyxoid fibroma.
    Granter SR; Renshaw AA; Kozakewich HP; Fletcher JA
    Mod Pathol; 1998 Nov; 11(11):1071-4. PubMed ID: 9831204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal karyotypic aberrations in enchondromas.
    Bridge JA; Persons DL; Neff JR; Bhatia P
    Cancer Detect Prev; 1992; 16(4):215-9. PubMed ID: 1458512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
    Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative genomic hybridization in cartilaginous tumors.
    Ozaki T; Wai D; Schäfer KL; Lindner N; Böcker W; Winkelmann W; Dockhorn-Dworniczak B; Poremba C
    Anticancer Res; 2004; 24(3a):1721-5. PubMed ID: 15274346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cartilage-forming tumors.
    Qasem SA; DeYoung BR
    Semin Diagn Pathol; 2014 Jan; 31(1):10-20. PubMed ID: 24680178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions.
    Bridge JA; Bhatia PS; Anderson JR; Neff JR
    Cancer Genet Cytogenet; 1993 Sep; 69(2):79-90. PubMed ID: 8402563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing of fibronectin transcripts in osteochondrogenic tumors.
    Matsui Y; Nakata K; Araki N; Ozono K; Fujita Y; Tsumaki N; Kawabata H; Yasui N; Sekiguchi K; Yoshikawa H
    Anticancer Res; 2001; 21(2A):1103-6. PubMed ID: 11396146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign cartilaginous tumors of bone: from morphology to somatic and germ-line genetics.
    Romeo S; Hogendoorn PC; Dei Tos AP
    Adv Anat Pathol; 2009 Sep; 16(5):307-15. PubMed ID: 19700940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benign cartilaginous tumors].
    Erlemann R
    Radiologe; 2001 Jul; 41(7):548-59. PubMed ID: 11490775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for telomeric fusions as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone.
    Sawyer JR; Goosen LS; Binz RL; Swanson CM; Nicholas RW
    Cancer Genet Cytogenet; 2005 May; 159(1):32-6. PubMed ID: 15860354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytogenetic changes in low grade central osteosarcomas].
    Werner M; Rieck J; Delling G
    Verh Dtsch Ges Pathol; 1998; 82():189-94. PubMed ID: 10095432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal chromosome abnormalities in enchondromas and chondrosarcomas.
    Gunawan B; Weber M; Bergmann F; Wildberger J; Niethard FU; Füzesi L
    Cancer Genet Cytogenet; 2000 Jul; 120(2):127-30. PubMed ID: 10942802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic findings in clear cell chondrosarcoma.
    Nishio J; Reith JD; Ogose A; Maale G; Neff JR; Bridge JA
    Cancer Genet Cytogenet; 2005 Oct; 162(1):74-7. PubMed ID: 16157204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.
    Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I
    Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic profile of 109 lipomas.
    Sreekantaiah C; Leong SP; Karakousis CP; McGee DL; Rappaport WD; Villar HV; Neal D; Fleming S; Wankel A; Herrington PN
    Cancer Res; 1991 Jan; 51(1):422-33. PubMed ID: 1988102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic analysis of aggressive meningiomas: possible diagnostic and prognostic implications.
    Perry A; Jenkins RB; Dahl RJ; Moertel CA; Scheithauer BW
    Cancer; 1996 Jun; 77(12):2567-73. PubMed ID: 8640707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.